Plasma and cerebrospinal fluid pharmacokinetics of cytosine arabinoside in dogs

Cancer Chemotherapy and Pharmacology

Volumn 29, Issue 1, 1991, Pages 13-18

  Scott Moncrieff, J Catharine R ^a   Chan, Thomas C K ^b   Samuels, Myra L ^c   Cook, James R ^a   Coppoc, Gordon L ^b   DeNicola, Dennis B ^a   Richardson, Ralph C ^a  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

^c PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD TOXICITY; CONTROLLED STUDY; DOG; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DRUG HALF LIFE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PHARMACOKINETICS; PRIORITY JOURNAL;

ANIMAL; BLOOD-BRAIN BARRIER; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTARABINE; DOGS; HALF-LIFE; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; MALE; SENSITIVITY AND SPECIFICITY; SUPPORT, NON-U.S. GOV'T; TIME FACTORS;

EID: 0026046224     PISSN: 03445704     EISSN: 14320843     Source Type: Journal    
DOI: 10.1007/BF00686329     Document Type: Article

References (36)

1. Pharmacology studies of 1β- d-arabinofuranosylcytosine in pediatric patients with leukemia and lymphoma after a biochemically optimal regimen of loading bolus plus continuous infusion of the drug
2. Treatment of central nervous system leukemia with intrathecal cytosine arabinoside
3. Clinical results and pharmacokinetics of high-dose cytosine arabinoside (HD ARA-C)
4. Alteration of the pharmacokinetics of high-dose ara-C by its metabolite ara-U in patients with acute leukemia
5. Treatment of adults with acute myelogenous leukemia: prospective evaluation of high-dose cytarabine in consolidation chemotherapy and with bone marrow transplantation
6. Central nervous system lymphosarcoma in the dog
7. Lymphosarcoma (malignant lymphoma) in the dog: diagnosis and treatment
8. Comparison of plasma and cerebrospinal fluid pharmacokinetics of high-dose versus intermediatedose cytosine arabinoside
9. Circulating carrier erythrocytes: slow-release vehicle for an antileukemic drug, cytosine arabinoside
10. A pilot study of high-dose 1-β- d-arabinofuranosylcytosine for acute leukemia and refractory lymphoma: clinical response and pharmacology
11. Distribution and metabolism of liposome-encapsulated and free 1-β- d-arabinofuranosylcytosine (ara-C) in dog and mouse tissues
12. Successful treatment of meningeal leukemia using systemic high-dose cytosine arabinoside
13. Intrathecal cytosine arabinoside for the treatment of meningeal metastases from malignant brain tumors and systemic tumors
14. Advances in the treatment of acute myelogenous leukemia
15. Effects of high-dose cytarabine
16. Pharmacokinetics of cytosine arabinoside in patients with acute myeloid leukaemia
17. Involvement of the central nervous system by non-Hodgkin's lymphoma
18. Clinical pharmacology of 1-β- d-arabinofuranosylcytosine
19. Pharmacologic studies of cyclocytidine and arabinosylcytosine in dogs
20. Effects of hypertonic glucose and mannitol on plasma volume
21. Adult acute leukemia. Frequency of central nervous system involvement in long term survivors
22. Pharmacology and toxicology of a seven-day infusion of 1-β- d-arabinofuranosylcytosine plus uridine in dogs
23. Ara-C pharmacokinetics in meningeal leukemia treatment
24. Acute myelomonocytic leukemia in a dog
25. Pharmacokinetic parameters of 1-β- d-arabinofuranosylcytosine (ara-C) and their relationship to intracellular metabolism of ara-C, toxicity, and response of patients with acute non-lymphocytic leukemia treated with conventional and high-dose ara-C
26. The pharmacokinetics of cytosine arabinoside in the plasma and cerebrospinal fluid during conventional and high-dose therapy
27. Prolonged high-dose ara-C infusions in acute leukemia
28. Natural history of central nervous system acute leukemia in adults
29. Cytosine arabinoside plus cisplatin and other drugs as chemotherapy for gliomas
30. Use of cytosar in pediatric acute myelocytic leukemia and leukemic meningitis
31. Cyclophosphamide, vincristine, methotrexate with leucoverin rescue and cytarabine (COMLA) combination sequential chemotherapy for advanced diffuse histiocytic lymphoma
32. Chemoimmunotherapy for canine lymphosarcoma
33. Pharmacokinetics of cytosine arabinoside in acute myeloid leukemia
34. Intrathecal arabinosyl cytosine in meningeal leukemia
35. Chemotherapeutic responses in dogs with lymphosarcoma and hypercalcemia
36. Intrathecal chemotherapy in Burkitt's lymphoma